CD163 and neoplasm: Immunohistochemistry revealed no differences in FOXP3-positive cells or CD8-T cells, but there was a marked increase in CD163-positive cells in the metastatic lesions, especially in the liver metastasis, compared to the primary tumor (Fig. 2f).